PART I Overview Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. As the innovators of ENHANZE drug delivery technology (ENHANZE) with our proprietary enzyme, rHuPH20, our commercially validated solution is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced trea...
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001159036-26-000024 | EDGAR | 75K words |
| 2025-02-18 | 2024-12-31 | 0001159036-25-000010 | EDGAR | — |
| 2024-02-20 | 2023-12-31 | 0001159036-24-000008 | EDGAR | — |
| 2023-02-21 | 2022-12-31 | 0001159036-23-000012 | EDGAR | — |
| 2022-02-22 | 2021-12-31 | 0001159036-22-000014 | EDGAR | — |
| 2021-02-23 | 2020-12-31 | 0001159036-21-000014 | EDGAR | — |
| 2020-02-24 | 2019-12-31 | 0001159036-20-000013 | EDGAR | — |
| 2019-02-21 | 2018-12-31 | 0001159036-19-000006 | EDGAR | — |
| 2018-02-20 | 2017-12-31 | 0001159036-18-000011 | EDGAR | — |
| 2017-02-28 | 2016-12-31 | 0001159036-17-000014 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001159036-26-000104 | EDGAR | — |
| 2025-11-03 | 2025-09-30 | 0001159036-25-000045 | EDGAR | 34K words |
| 2025-08-05 | 2025-06-30 | 0001159036-25-000034 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0001159036-25-000026 | EDGAR | — |
| 2024-10-31 | 2024-09-30 | 0001159036-24-000050 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001159036-24-000044 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001159036-24-000037 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0001159036-23-000057 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001159036-23-000048 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001159036-23-000039 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001159036-22-000059 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001159036-22-000050 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001159036-26-000103 | EDGAR | — |
| 2026-03-12 | 0001159036-26-000035 | EDGAR | 1K words |
| 2026-02-17 | 0001159036-26-000023 | EDGAR | — |
| 2026-01-28 | 0001159036-26-000011 | EDGAR | — |
| 2025-12-09 | 0001159036-25-000070 | EDGAR | — |
| 2025-12-08 | 0001159036-25-000068 | EDGAR | — |
| 2025-11-24 | 0001159036-25-000061 | EDGAR | — |
| 2025-11-12 | 0001193125-25-277988 | EDGAR | — |
| 2025-11-07 | 0001159036-25-000049 | EDGAR | — |
| 2025-11-05 | 0001159036-25-000047 | EDGAR | — |
273 total filings indexed. 241 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001159036 |
| Ticker | HALO |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.halozyme.com |
| Listed | 2004-03-12 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HALO (~200 tokens, structured JSON with cryptographic provenance)